Varaico: Literature-Extracted Genetic Variants

Gene:GCDH
Variant:p.S139L
Back to variants list

GCDH

NM_000159.4:p.S139L

Associated Papers

The genetic spectrum features of 2261 Chinese children with epilepsy and intellectual disability.

Pang N et al.

Bmc Medicine, 2025

40598568 (PubMed )
Supplement: 12916_2025_4220_MOESM1_ESM.xlsx › Table_S3

Prevalence of inherited metabolic disorders among newborns in Zhuzhou, a southern city in China.

Luo H et al.

Frontiers in Genetics, 2024

Compilation of Genotype and Phenotype Data in GCDH-LOVD for Variant Classification and Further Application.

Tibelius A et al.

Genes, 2023

Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey.

Bozaci AE et al.

Molecular Genetics and Metabolism Reports, 2023

Chinese genetic variation database of inborn errors of metabolism: a systematic review of published variants in 13 genes.

Guo Y et al.

Orphanet Journal of Rare Diseases, 2023

37308883 (PubMed )
Supplement: 13023_2023_2726_MOESM1_ESM.xlsx › Table_S1

2-Methylglutaconic acid as a biomarker in routine urine organic acids leading to the diagnosis of glutaric acidemia type I in a low excretor.

Wongkittichote P et al.

Molecular Genetics and Metabolism, 2023

The outcome of 41 Late-Diagnosed Turkish GA-1 Patients: A Candidate for the Turkish NBS.

Kılavuz S et al.

Neuropediatrics, 2021

Evaluation of the Clinical, Biochemical, Neurological, and Genetic Presentations of Glutaric Aciduria Type 1 in Patients From China.

E H et al.

Frontiers in Genetics, 2021

Functional Recovery of a GCDH Variant Associated to Severe Deflavinylation-Molecular Insights into Potential Beneficial Effects of Riboflavin Supplementation in Glutaric Aciduria-Type I Patients.

Ribeiro JV et al.

International Journal of Molecular Sciences, 2020

Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1.

Zayed H et al.

Metabolic Brain Disease, 2019

Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I.

Mosaeilhy A et al.

Metabolic Brain Disease, 2017

Reversible brain atrophy in glutaric aciduria type 1.

Numata-Uematsu Y et al.

Brain & Development, 2017

Clinical and molecular investigation in Chinese patients with glutaric aciduria type I.

Zhang Y et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2016

MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites.

Fukasawa Y et al.

Molecular & Cellular Proteomics : Mcp, 2015

25670805 (PubMed )
Supplement: supp_M114.043083_mcp.M114.043083-16.xlsx › TableS9A

Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1.

Mushimoto Y et al.

Molecular Genetics and Metabolism, 2011

Glutaric aciduria type 1 in Korea: report of two novel mutations.

Park JD et al.

Journal of Korean Medical Science, 2010

Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.

Ryu GM et al.

Nucleic Acids Research, 2009

19139070 (PubMed )
Supplement: gkn1008_nar-01723-s-2008-File009.xls › TypeI-

Riboflavin-responsive glutaryl CoA dehydrogenase deficiency.

Chalmers RA et al.

Molecular Genetics and Metabolism, 2006

Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer.

Westover JB et al.

Molecular Genetics and Metabolism, 2003

Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations.

Goodman SI et al.

Human Mutation, 1998

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."